[High dose of pegylated interferon alpha-2a for the treatment of genotype1 chronic hepatitis C: a case report].
Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China. wuchihong1@sohu.com
Chi-hong
CH
Wu
Li-fen
LF
Wang
Xiao-yuan
XY
Xu
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a